Show
Sort by
-
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
-
Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases
-
Crohn's disease and month of birth
-
Environmental factors in familial Crohn's disease in Belgium
-
Study on CARD15 and TLR4 polymorphisms in children with early diagnosed IBD and their family members
-
Genome wide scan in a Flemish inflammatory bowel disease population : support for the IBD4 locus, population heterogeneity, and epistasis
-
Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease
-
Pancreatic autoantibodies in inflammatory bowel disease
-
Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis
-
The value of serologic markers in indeterminate colitis : a prospective follow-up study : reply
-
Transmission of CARD15 (NOD2) variants in families with Crohns disease
-
Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease : a prospective cohort study
-
The value of serologic markers in indeterminate colitis : a prospective follow-up study
-
Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
-
Diagnostic value of anti-Saccharomyces cerevisae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
-
Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families
-
Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.